Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy Growth Corp. is announcing a bankruptcy filing for its BioSteel sports drink in Canada and the U.S. on Thursday in a move by the cannabis company to strengthen its financial position, MarketWatch has learned.

Canopy Growth's BioSteel sports drink unit files for bankruptcy in a move to stem cash burn

BioSteel filing immediately eliminates significant cash burn for Canopy Growth and provides for an orderly realization of value of BioSteel's assets through a sale process As the senior secured lender to BioSteel, Canopy Growth expects to recover proceeds from the anticipated sale process  Management reaffirms its expectation to achieve positive Adjusted EBITDA in all remaining business units exiting FY2024 , as the Company focuses on driving growth in its Canadian and U.S. cannabis businesses to position itself as an industry leader in North America SMITHS FALLS, ON , Sept. 14, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) today announced that it has ceased funding BioSteel Sports Nutrition Inc. ("BioSteel") and that BioSteel has commenced proceedings under the Companies' Creditors Arrangement Act (the "CCAA") in the Ontario Superior Court of Justice (Commercial List) ("CCAA Court") and will seek recognition of that proceeding under Chapter 15 of the United States Bankruptcy Code to give full force and effect to the orders made in the CCAA proceeding in the United States, including a stay of proceedings.

Canopy Growth to Cease Funding BioSteel Business Unit Furthering Business Transformation and Focus on North American Cannabis Leadership

Aurora Cannabis

All across Washington, D.C., prospects for marijuana legalization are improving.

Why Canopy Growth, Aurora Cannabis, and Cresco Labs Stocks Sank Today

Tilray Brands

The cannabis market is in disarray. In Canada, where the recreational drug was legalized nationwide in 2018, the market has all but collapsed.

The 3 Most Undervalued Cannabis Stocks to Buy in September 2023

Canopy Growth Corp.'s stock CGC fell about 7% in premarket trading on Wednesday on volume of two million shares, as investors continued to focus on the cannabis stock. The company said Wednesday it'll take part in investor conferences including the ATB Capital Markets 2023 Life Sciences Institutional Investor Conference on Sept.

Canopy Growth stock continues slide after big runup

Anheuser-Busch InBev

MedMen Enterprises Inc.

SNDL Inc.

Many of the most popular cannabis stocks trade on the Nasdaq, including Canopy Growth, Tilray Brands, and SNDL. These businesses operate in the struggling Canadian pot market amid choking competition.

What Is the Nasdaq's Best Cannabis Stock?

SMITHS FALLS, ON , Sept. 13, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announced planned participation at investor conferences and events in September.

Canopy Growth Announces Fall 2023 Investor Conference and Event Participation

After amazing gains Monday, two of these cannabis stocks dropped Tuesday morning -- while one continued to pop. New bills in Congress are adding confusion to the marijuana legalization picture.

Why Canopy Growth, Aurora Cannabis, and Tilray Stocks Are All Over the Map Today

Canopy Growth Corporation (TSX:WEED, NYSE:CGC) stock fell about 10% on Tuesday morning as investors pulled back on the stock following Monday's surge. Shares of the cannabis company fell about 9.7% to $1.53 at 10.30 am, after the stock booked an 81.4% gain to US$1.69 at Monday's close.

Canopy Growth stock slides as investors pull back on pot stocks

Canopy Growth Corp.'s stock CGC, -0.59% moved up by 10% Tuesday after it more than doubled in the two previous days. The stock had fallen as much as 18% in morning trades, before moving into positive territory.

Canopy Growth's stock stays hot after big gains, but some cannabis stocks cool

The world of investing and trading is abuzz with excitement as one sector theme has recently emerged as a blazing hot topic of discussion: cannabis stocks.

Cannabis Stocks: Green Gold Rush or Risk Off?

FuelCell Energy

Nikola

Some penny stocks go on to deliver huge returns for their owners. Most, however, do not.

3 Penny Stocks to Sell in September Before They Crash & Burn

Aurora Cannabis is paying down debt -- and promising positive free cash flow (FCF) in 2024. Wall Street analysts don't think the company will be FCF-profitable before 2026.

Why Canopy Growth, Aurora Cannabis, and Tilray Stocks All Exploded Higher Today

The positive performance of cannabis stocks last week driven by enthusiasm around the potential rescheduling of marijuana as a lower-risk drug in the U.S. is set to continue as progress is made on cannabis banking reform in the country, according to analysts at Water Tower Research.

Cannabis MSO winning streak expected to continue as lawmakers vote on SAFE Banking Act

Canopy Growth (NASDAQ: CGC ) stock fans will want to check in on the company when Sept. 25 rolls around for a potential catalyst.

Dear CGC Stock Fans, Mark Your Calendars for Sept. 25

It might not seem like penny stocks and Twinkies go together. But with the latest surge in marijuana stocks, Hostess stock might not be the worst complement to the cannaboom in 2023.

3 Marijuana Penny Stocks To Watch After Hostess Stock News

Shares of Canopy Growth Corporation (TSX:WEED, NYSE:CGC) had added almost 50% on Monday morning, sending its share price back above $1, as cannabis stocks continued to benefit from the news that U.S. health officials have recommended the re-scheduling of marijuana as a lower-risk drug.

Canopy Growth and other pot stocks surge on marijuana rescheduling optimism

Canopy Growth (NASDAQ: CGC) stock price has made a strong comeback in the past few days as investors cheer some good news about the pot industry. The shares rose above $1 for the first time since June this year.

Canopy Growth stock price could double to $2 but risks remain

Shareholders are Encouraged to Vote Well in Advance of the Proxy Deadline of 1:00 p.m. (Eastern time) on September 21, 2023 Your Vote is Important!

Canopy Growth Reminds Shareholders to Cast Their Vote for Upcoming Annual General and Special Meeting of Shareholders to be held on September 25, 2023 at 1:00 p.m. (Eastern time)

Canopy Growth Corp. CGC, +22.61% stock was up 9.5% in premarket trades Monday, to put it on track to trade above $1 for the first time since May. The gain comes after a nearly 23% rally in the previous session to finish out a strong week for cannabis stocks.

Canopy Growth stock trades above $1 for first time since May

Curaleaf Holdings, Inc.

IM Cannabis Corp

With cannabis usage continuing to rise, now could be an opportune time to invest in marijuana stocks. Over 52 million Americans currently use cannabis, and legalization seems inevitable as more states approve recreational and medical use.

The 3 Best Cannabis Stocks to Buy Now: September 2023

Momentum for passage of marijuana reform legislation keeps growing, and senators are confident the SAFE Banking Act will pass. A new study touts the benefits of medical marijuana for pain amelioration.

Why Canopy Growth, Aurora Cannabis, and Curaleaf Stocks All Popped Today

Shares of Canopy Growth Corp. CGC, +22.72% shot up 21.7% toward a near four-month high in very active afternoon trading, putting them on track for the fifth double-digit percentage gain in seven sessions. The stock has rocketed 130% over the past seven session.

Canopy Growth stock soars on heavy volume again, amid cannabis investor optimism over possible favorable legislation

Cronos Group

Marijuana penny stocks and higher-priced cannabis stocks are having a moment in the stock market right now. Mainstream stock market news is about inflation being high, and considered a negative.

Marijuana Penny Stocks Are On Fire, 3 To Watch Right Now

The recent bull run on the Canadian pot purveyor ended, following news of insider share sales. Three members of the board of directors unloaded pieces of their holdings.

News for Canopy Growth Stock (CGC)